Skip to content

Prediction of requirement of hypoglycemic therapies for hyperglycemia induced by steroidal treatment for collagen vascular disease, etc.

Prediction of requirement of hypoglycemic therapies for hyperglycemia induced by steroidal treatment for collagen vascular disease, etc. - Developing and validation of the scoring system for prediction of requirement of hypoglycemic therapies including insulin for hyperglycemia during glucocorticoid treatment (Multicenter Retrospective Study)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000027704
Enrollment
700
Registered
2017-06-09
Start date
2017-06-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glucocorticoid-induced diabetes

Interventions

None listed

Sponsors

Gifu University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Developing set patients admitted in Department of General Internal Medicine, Gifu University Hospital between 1 June 2004 and 31 July 2016. Validation set A: admitted in Department of General Internal Medicine, Gifu Prefectural General Medical Center between 1 April 2012 and 31 July 2016. B: admitted in Center of General Internal Medicine and Rheumatology, Gifu Municipal Hospital between 1 April 2012 and 31 July 2016. Inclusion criteria applied to the Developing set, and Validation set A and B indicate that patients were 20 years of age or older and the glucocorticoid treatment with the dosage of prednisolone more than 5 mg/day for 4 weeks at least was administered for the first time.

Exclusion criteria

Exclusion criteria: Exclusion criterion indicates taking concomitantly anti-cancer drugs

Design outcomes

Primary

MeasureTime frame
Administration of insulin therapy during glucocorticoid treatment

Secondary

MeasureTime frame
Administration of oral hypoglycemic agentsand glucagon like peptide 1 receptor agonist

Countries

Japan

Contacts

Public ContactMikako Kawashima

Gifu University Hospital Department of General Internal Medicine

oida@gifu-u.ac.jp058-230-6632

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026